Today I’m joined by Henry O’Connell, CEO & Founder of Canary Speech, the company pioneering AI-powered vocal biomarkers to detect diseases like Alzheimer’s, Parkinson’s, and other neurological and behavioural conditions, all through a 20–30 second voice sample.

In this episode, we explore:

1. How Canary Speech was founded and where the idea came from
2. Why holding 14 patents in vocal biomarker technology is such a competitive advantage
3. How Canary ensures clinical-grade safety, trust, and bias mitigation in AI healthcare tools
4. The latest innovations in aggression detection, neurological disorders & behavioural health
5. How global regulation (U.S. vs Europe vs Asia) shapes adoption speed in healthcare AI

If you’re interested in AI, healthcare, digital biomarkers, clinical innovation, or the future of diagnostics, this episode is a must-listen.